High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

NCT02597062 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]